These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 3522040)

  • 1. Iohexol 240 mgr I/ml and metrizamide 240 mgr I/ml in lumbar myelography. Report from a randomized double blind study.
    Valk J; Hazenberg GJ; van Duijn H; Crezee F; Olislagers-De Slegte R
    Diagn Imaging Clin Med; 1986; 55(3):114-20. PubMed ID: 3522040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A randomized, double-blind clinical trial of 2 nonionic contrast media for myelography].
    Lovrencić M; Klanfar Z; Jakovac I
    Lijec Vjesn; 1986 Apr; 108(4):141-6. PubMed ID: 3520199
    [No Abstract]   [Full Text] [Related]  

  • 3. Iohexol: summary of North American and European clinical trials in adult lumbar, thoracic, and cervical myelography with a new nonionic contrast medium.
    Shaw DD; Bach-Gansmo T; Dahlstrom K
    Invest Radiol; 1985; 20(1 Suppl):S44-50. PubMed ID: 3882616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of iohexol with metrizamide in myelography.
    Sortland O; Nestvold K; Kloster R; Aandahl MH
    Radiology; 1984 Apr; 151(1):121-2. PubMed ID: 6701301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iotrol versus metrizamide in lumbar myelography: a double-blind study.
    Malnor MD; Houston LW; Strother CM; Turski PA; Sackett JF; Boyer M
    Radiology; 1986 Mar; 158(3):845-7. PubMed ID: 3945762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lumbar myelography with iohexol and metrizamide. A comparative multicenter prospective study.
    Kieffer SA; Binet EF; Davis DO; Gabrielsen TO; Kido DK; Latchaw RE; Turski PA; Shaw DD
    Invest Radiol; 1985; 20(1 Suppl):S22-30. PubMed ID: 3882614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lumbar myelography with iohexol and metrizamide: a comparative multicenter prospective study.
    Kieffer SA; Binet EF; Davis DO; Gabrielsen TO; Kido DK; Latchaw RE; Turski PA; Shaw DD
    Radiology; 1984 Jun; 151(3):665-70. PubMed ID: 6371890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iohexol compared to metrizamide in cervical and thoracic myelography. A randomized double blind parallel study.
    Nakstad P; Helgetveit A; Aaserud O; Ganes T; Nyberg-Hansen R
    Neuroradiology; 1984; 26(6):479-84. PubMed ID: 6390248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iohexol: a new nonionic contrast medium for myelography and cisternography with markedly reduced neurotoxicity.
    Gonsette RE; Liesenborghs L
    Invest Radiol; 1985; 20(1 Suppl):S32-6. PubMed ID: 3871751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iohexol versus metrizamide for lumbar myelography: double-blind trial.
    Gabrielsen TO; Gebarski SS; Knake JE; Latack JT; Yang PJ; Hoff JT
    AJR Am J Roentgenol; 1984 May; 142(5):1047-9. PubMed ID: 6372410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iohexol versus metrizamide for lumbar myelography: preliminary report of double-blind trial.
    Gebarski SS; Gabrielsen TO; Knake JE; Latack JT; Hoff JT
    Neurosurgery; 1984 Jan; 14(1):19-21. PubMed ID: 6363962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between contrast medium dose and adverse effects in lumbar myelography.
    Wilmink JT; Lindeboom SF; Vencken LM; vd Burg W
    Diagn Imaging Clin Med; 1984; 53(4):208-14. PubMed ID: 6380885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safer lumbar myelograms--the search continues.
    Mason K
    Can Nurse; 1983 Jun; 79(6):28. PubMed ID: 6552927
    [No Abstract]   [Full Text] [Related]  

  • 14. Lumbar myelography with iohexol and metrizamide. A double-blind clinical trial.
    Hindmarsh T; Ekholm SE; Kido DK; Sahler L; Sands M
    Acta Radiol Diagn (Stockh); 1984; 25(5):365-8. PubMed ID: 6507131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and affective changes after myelography: a comparison of metrizamide and iohexol.
    Ratcliff G; Sandler S; Latchaw R
    AJR Am J Roentgenol; 1986 Oct; 147(4):777-81. PubMed ID: 3489380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials with iotrolan in myelographic and computed tomography applications in the United States.
    Goldstein HA; Pfennig D
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():167-70. PubMed ID: 2568788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iohexol and ioxithalamate for intravenous urography. A comparative parallel study.
    Egeblad M; Nielsen NT; Fries J; Laulund S
    Eur J Radiol; 1985 Aug; 5(3):240-2. PubMed ID: 3896801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iohexol versus metrizamide for cervical myelography: double-blind trial.
    Gebarski SS; Gabrielsen TO; Knake JE; Latack JT; Yang PJ; Hoff JT
    AJNR Am J Neuroradiol; 1985; 6(6):923-6. PubMed ID: 3934930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical myelography with iohexol and metrizamide. A randomized double blind clinical study.
    Servo A; Porras M; Jääskinen J; Virta A; Laasonen EM
    Acta Radiol Suppl; 1986; 369():528-31. PubMed ID: 2980548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychic changes following myelography with metrizamide and iohexol. A comparative investigation with psychologic tests.
    Cronqvist SE; Holtås SL; Laike T; Ozolins A
    Acta Radiol Diagn (Stockh); 1984; 25(5):369-73. PubMed ID: 6507132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.